Search
for

    Research 2 of 20

    1. 415 Targeting inflammation and specialized pro-resolving mediators to reinforce barrier function and scalp homeostasis. Journal of Investigative Dermatology · 2022
    2. Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report International Journal of Rheumatic Diseases · 2024 · 2 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →